• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泛素特异性蛋白酶 1 通过稳定 c-MYC 促进膀胱癌进展。

Ubiquitin-Specific Protease 1 Promotes Bladder Cancer Progression by Stabilizing c-MYC.

机构信息

Department of Laboratory Medicine, School of Medicine, Hunan Normal University, Changsha 410013, China.

School of Medicine, Chongqing University, Chongqing 400030, China.

出版信息

Cells. 2024 Oct 30;13(21):1798. doi: 10.3390/cells13211798.

DOI:10.3390/cells13211798
PMID:39513905
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11545376/
Abstract

BACKGROUND

Ubiquitination is an important post-transcriptional modification crucial for maintaining cell homeostasis. As a deubiquitination enzyme, ubiquitin-specific protease 1 (USP1) is associated with tumor progression; however, its role in bladder cancer is unknown. This study aimed to analyze USP1 expression and study its roles in bladder cancer.

METHODS

The web server GEPIA was used to analyze the USP1 expression. To explore USP1's function in bladder cancer, we constructed USP1-knockout cell lines in UMUC3 cells. A FLAG-USP1 (WT USP1) plasmid and a plasmid FLAG-USP1 C90S (catalytic-inactive mutant) were used to overexpress USP1 in T24 cells. CCK8, colony formation, and Transwell assays were used to assess cell viability, proliferation, and migration. RNA-sequencing (RNA-seq) and dual-luciferase reporter assays were performed to screen the pathway. Co-immunoprecipitation and immunofluorescence were used to explore the interaction between USP1 and c-MYC. A xenograft mouse model was used to study the role of USP1 in bladder cancer.

RESULTS

USP1 expression was upregulated in human bladder cancer cells and correlated with poor patient prognosis. USP1 overexpression promoted cell proliferation, clone formation, and migration, and this was attenuated by genetic ablation of USP1. Furthermore, we observed that deficiency inhibited tumor formation in vivo. Mechanistically, the c-MYC pathway was remarkably activated compared with the other pathways. Furthermore, USP1 could interact with c-MYC and increase c-MYC's stability depending on the catalytic activity of USP1.

CONCLUSIONS

Our results suggested that high expression of USP1 promotes bladder cancer progression by stabilizing c-MYC; hence, USP1 may serve as a novel therapeutic target for treating bladder cancer.

摘要

背景

泛素化是一种重要的转录后修饰,对于维持细胞内稳态至关重要。作为一种去泛素化酶,泛素特异性蛋白酶 1(USP1)与肿瘤进展有关;然而,其在膀胱癌中的作用尚不清楚。本研究旨在分析 USP1 的表达,并研究其在膀胱癌中的作用。

方法

使用 web 服务器 GEPIA 分析 USP1 的表达。为了探讨 USP1 在膀胱癌中的功能,我们在 UMUC3 细胞中构建了 USP1 敲除细胞系。使用 FLAG-USP1(WT USP1)质粒和质粒 FLAG-USP1 C90S(催化失活突变体)在 T24 细胞中过表达 USP1。使用 CCK8、集落形成和 Transwell 测定评估细胞活力、增殖和迁移。进行 RNA 测序(RNA-seq)和双荧光素酶报告基因测定筛选通路。使用 co-immunoprecipitation 和免疫荧光来探索 USP1 和 c-MYC 之间的相互作用。使用异种移植小鼠模型研究 USP1 在膀胱癌中的作用。

结果

USP1 在人膀胱癌细胞中表达上调,并与患者预后不良相关。USP1 的过表达促进了细胞增殖、克隆形成和迁移,而 USP1 的遗传缺失则减弱了这一作用。此外,我们观察到缺陷抑制了体内肿瘤的形成。机制上,与其他通路相比,c-MYC 通路显著被激活。此外,USP1 可以与 c-MYC 相互作用,并依赖于 USP1 的催化活性增加 c-MYC 的稳定性。

结论

我们的结果表明,高表达的 USP1 通过稳定 c-MYC 促进膀胱癌的进展;因此,USP1 可能成为治疗膀胱癌的一种新的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cda/11545376/339ac8ea36f9/cells-13-01798-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cda/11545376/e0e87c85fbd8/cells-13-01798-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cda/11545376/e8a7392df33d/cells-13-01798-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cda/11545376/d85d745aad44/cells-13-01798-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cda/11545376/060cc6d13628/cells-13-01798-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cda/11545376/aa449fbd0827/cells-13-01798-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cda/11545376/339ac8ea36f9/cells-13-01798-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cda/11545376/e0e87c85fbd8/cells-13-01798-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cda/11545376/e8a7392df33d/cells-13-01798-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cda/11545376/d85d745aad44/cells-13-01798-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cda/11545376/060cc6d13628/cells-13-01798-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cda/11545376/aa449fbd0827/cells-13-01798-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cda/11545376/339ac8ea36f9/cells-13-01798-g006.jpg

相似文献

1
Ubiquitin-Specific Protease 1 Promotes Bladder Cancer Progression by Stabilizing c-MYC.泛素特异性蛋白酶 1 通过稳定 c-MYC 促进膀胱癌进展。
Cells. 2024 Oct 30;13(21):1798. doi: 10.3390/cells13211798.
2
USP1-mediated deubiquitination of KDM1A promotes the malignant progression of triple-negative breast cancer.USP1 介导的 KDM1A 去泛素化促进三阴性乳腺癌的恶性进展。
J Biochem Mol Toxicol. 2024 Oct;38(10):e23864. doi: 10.1002/jbt.23864.
3
The KLF16/MYC feedback loop is a therapeutic target in bladder cancer.KLF16/MYC 反馈回路是膀胱癌的治疗靶点。
J Exp Clin Cancer Res. 2024 Nov 18;43(1):303. doi: 10.1186/s13046-024-03224-3.
4
CXCR4 up-regulation mediated by USP1 deubiquitination promotes the tumorigenesis and immune escape in esophageal squamous-cell carcinoma.USP1 去泛素化介导的 CXCR4 上调促进食管鳞癌的发生发展和免疫逃逸。
J Biochem Mol Toxicol. 2024 Nov;38(11):e70004. doi: 10.1002/jbt.70004.
5
USP5 facilitates bladder cancer progression by stabilizing the c-Jun protein.USP5通过稳定c-Jun蛋白促进膀胱癌进展。
Cancer Cell Int. 2024 Jan 16;24(1):32. doi: 10.1186/s12935-024-03222-7.
6
Targeting USP1-dependent KDM4A protein stability as a potential prostate cancer therapy.靶向 USP1 依赖性 KDM4A 蛋白稳定性作为一种潜在的前列腺癌治疗方法。
Cancer Sci. 2020 May;111(5):1567-1581. doi: 10.1111/cas.14375. Epub 2020 Mar 30.
7
USP1 promotes pancreatic cancer progression and autophagy by deubiquitinating ATG14.USP1通过去泛素化ATG14促进胰腺癌进展和自噬。
J Biol Chem. 2025 Mar;301(3):108190. doi: 10.1016/j.jbc.2025.108190. Epub 2025 Jan 13.
8
Ubiquitin-specific protease 1 acts as an oncogene and promotes lenvatinib efficacy in hepatocellular carcinoma by stabilizing c-kit.泛素特异性蛋白酶1作为一种癌基因,通过稳定c-kit促进肝癌中乐伐替尼的疗效。
Ann Hepatol. 2022 Mar-Apr;27(2):100669. doi: 10.1016/j.aohep.2022.100669. Epub 2022 Jan 16.
9
Tumor suppressor functions of miRNA-375 in nasopharyngeal carcinoma through inhibition of ubiquitin-specific protease 1 expression.miRNA-375 通过抑制泛素特异性蛋白酶 1 的表达抑制鼻咽癌中的肿瘤抑制功能。
Int J Biochem Cell Biol. 2021 Dec;141:106092. doi: 10.1016/j.biocel.2021.106092. Epub 2021 Oct 7.
10
C-MYC-activated lncRNA SNHG20 accelerates the proliferation of diffuse large B cell lymphoma via USP14-mediated deubiquitination of β-catenin.C-MYC 激活的长链非编码 RNA SNHG20 通过 USP14 介导的β-连环蛋白去泛素化加速弥漫性大 B 细胞淋巴瘤的增殖。
Biol Direct. 2024 Jun 18;19(1):47. doi: 10.1186/s13062-024-00488-9.

引用本文的文献

1
USP38: an important regulatory factor in tumor malignant progression.USP38:肿瘤恶性进展中的一个重要调节因子。
Front Immunol. 2025 Aug 27;16:1612723. doi: 10.3389/fimmu.2025.1612723. eCollection 2025.
2
Mitochondria-targeted antioxidant skq1 reverses functional impairment and histopathological insults in a chronic animal model of multiple sclerosis.线粒体靶向抗氧化剂SkQ1可逆转多发性硬化症慢性动物模型中的功能损伤和组织病理学损伤。
Metab Brain Dis. 2025 Aug 22;40(7):249. doi: 10.1007/s11011-025-01676-w.

本文引用的文献

1
USP5 facilitates bladder cancer progression by stabilizing the c-Jun protein.USP5通过稳定c-Jun蛋白促进膀胱癌进展。
Cancer Cell Int. 2024 Jan 16;24(1):32. doi: 10.1186/s12935-024-03222-7.
2
USP1 promotes cholangiocarcinoma progression by deubiquitinating PARP1 to prevent its proteasomal degradation.USP1 通过去泛素化 PARP1 来防止其蛋白酶体降解,从而促进胆管癌的进展。
Cell Death Dis. 2023 Oct 11;14(10):669. doi: 10.1038/s41419-023-06172-6.
3
USP1 modulates hepatocellular carcinoma progression via the Hippo/TAZ axis.USP1 通过 Hippo/TAZ 轴调节肝细胞癌进展。
Cell Death Dis. 2023 Apr 12;14(4):264. doi: 10.1038/s41419-023-05777-1.
4
Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer.高危非肌肉浸润性膀胱癌的新型治疗方法。
Curr Oncol Rep. 2023 Feb;25(2):83-91. doi: 10.1007/s11912-022-01350-9. Epub 2022 Dec 26.
5
Inhibition of USP1 activates ER stress through Ubi-protein aggregation to induce autophagy and apoptosis in HCC.USP1 的抑制通过泛素蛋白聚集激活 ER 应激,从而诱导 HCC 中的自噬和细胞凋亡。
Cell Death Dis. 2022 Nov 10;13(11):951. doi: 10.1038/s41419-022-05341-3.
6
Inhibition of USP1 reverses the chemotherapy resistance through destabilization of MAX in the relapsed/refractory B-cell lymphoma.USP1 抑制通过使复发/难治性 B 细胞淋巴瘤中的 MAX 不稳定来逆转化疗耐药性。
Leukemia. 2023 Jan;37(1):164-177. doi: 10.1038/s41375-022-01747-2. Epub 2022 Nov 9.
7
Inhibition of USP1 enhances anticancer drugs-induced cancer cell death through downregulation of survivin and miR-216a-5p-mediated upregulation of DR5.USP1 抑制通过下调 survivin 和 miR-216a-5p 介导的 DR5 上调增强抗癌药物诱导的癌细胞死亡。
Cell Death Dis. 2022 Sep 24;13(9):821. doi: 10.1038/s41419-022-05271-0.
8
ML323 suppresses the progression of ovarian cancer regulating USP1-mediated cell cycle.ML323通过调节USP1介导的细胞周期来抑制卵巢癌的进展。
Front Genet. 2022 Jul 18;13:917481. doi: 10.3389/fgene.2022.917481. eCollection 2022.
9
ML323, a USP1 inhibitor triggers cell cycle arrest, apoptosis and autophagy in esophageal squamous cell carcinoma cells.USP1 抑制剂 ML323 诱导食管鳞癌细胞周期停滞、凋亡和自噬。
Apoptosis. 2022 Aug;27(7-8):545-560. doi: 10.1007/s10495-022-01736-x. Epub 2022 Jun 2.
10
USP1 inhibition suppresses the progression of osteosarcoma via destabilizing TAZ.USP1 抑制通过使 TAZ 不稳定来抑制骨肉瘤的进展。
Int J Biol Sci. 2022 May 1;18(8):3122-3136. doi: 10.7150/ijbs.65428. eCollection 2022.